NCT00760331进行中（未招募）不适用
A Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function
University Hospital, Limoges1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
Anomalies of renal development are well know for patients treated for MODY-5 diabetes due to TCF2 mutation.A recent study confirms the existence of pediatric patients having TCF2 mutation but presenting renal anomalies alone.Endocrine and renal evolution of these patients is unknown.The aim of this study is to follow a cohort of patients with TCF2 mutation and initially presenting renal anomalies alone.
详细描述
Biologic analysis and renal ultrasonography once a year.
After puberty or before kidney transplantation
- Abdominal and pelvic MRI
- Intravenous Glucose Tolerance Test
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients presenting an anomaly of renal development due to TCF2 mutation
- •Age<18 years old
排除标准
- •Anomaly of renal development without TCF2 mutation
- •Age≥18 years old
- •Parents or patients refusing to participate to the study
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALLAcute Lymphoblastic Leukemia (ALL)NCT01305655Nordic Society for Pediatric Hematology and Oncology47
已完成
不适用
Nutritional, Metabolic and Respiratory Status in Cystic FibrosisDiabetesCystic FibrosisNCT00476281University Hospital, Strasbourg, France114
已完成
4 期
Growth and Development Study of Alglucosidase AlfaGlycogen Storage Disease Type II (GSD-II)Acid Maltase Deficiency DiseasePompe DiseaseNCT00486889Genzyme, a Sanofi Company12
已完成
不适用
Methylation Biosignature in Childhood Chronic Kidney DiseaseChronic Kidney DiseaseCardiovascular DiseaseNCT02022046Chang Gung Memorial Hospital69
已完成
不适用
Retrospective study in pediatric living renal transplant: a focus on onset of diuresisEnd-stage renal failureJPRN-UMIN000031210Tokyo Womens' Medical University40